93
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Omeprazole Does Not Interfere with the Antiplatelet Effect of Low-Dose Aspirin in Man

Pages 242-246 | Published online: 08 Jul 2009

References

  • References
  • Hennekens CH, Jonas MA, Buring JE. The benefits of aspirin in acute myocardial infarction: still a well-kept secret in the United States. Arch Intern Med 1994;154:37–9.
  • Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and non ulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992;103:862–9.
  • Garcia Rodriguez LA, Jick H. Risk if upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:769–72.
  • Hawkey CJ. Review article: aspirin and gastrointestinal bleeding. Aliment Pharmacol Ther 1994;8:141–6.
  • Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827–30.
  • Day JP, Lanas A, Rustagui P, Hirschowitz BI. Reversible prolonged skin bleeding time due to aspirin, found in acute GI bleeders but not in controls. J Clin Gastroenterol 1996;22:96–103.
  • Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo control trial. Ann Intern Med 1995;123:241–9.
  • Hawkey CJ, Prichard CJ, Somerville KW. Strategies for preventing aspirin-induced gastric bleeding. Scand J Gastroenterol 1986;Suppl 125:170–3.
  • Hawkey CJ, Swannell AJ, Eriksson S, Walan A, Bjersing M, Jalinder M, et al. Lower frecuency of gastroduodenal ulcers and erosions and dyspeptic symptoms in NSAID users during maintenance with omeprazole compared to ranitidine [abstract]. Gastroenterology 1996;110:A131.
  • Yeomans ND, Tulassay Z, Juhasz L, Racz Y, Howard JM, van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid suppression trial: ranitidine versus omeprazole for NSAIDs-associated ulcer treatment (ASTRONAUT study group). N Engl J Med 1998;338:719–26.
  • Brooks PM, Day RO. Drug therapy: nonsteroidal antiinflammatory drugs. Differences and similarities. N Engl J Med 1991;1716–25.
  • Dixon JS. Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues. Rheumatol Int 1991;11:13–8.
  • Milligan PA, McGill P, Howden CW, Kelman AW, Whiting BAD. The consequences of H2 receptor antagonists piroxicam coadministration in patients with joint disorders. Eur J Clin Pharmacol 1993;45: 507–12.
  • Said SA, Foda AMAD. Influence of cimetidine on the pharmacokinetics of piroxicam in rat and man. Arzneimittelforschung 1989;39:790–821.
  • Evans AM, Nation RL, Sansom LNAD. Lack of effect of cimetidine on the pharmacokinetics of R (−) and S (+) -ibuprofen. Br J Clin Pharmacol 1989;28:143–9.
  • Lichtenberger LM, Ullua C, Romero JJ, Vanous AL, Illich PA, Dial EJ. Nonsteroidal anti-inflammatory drugs and phospholipid prodrugs: combination therapy with antisecretory agent in rats. Gastroenterology 1996;111:990–5.
  • Giraud MN, Sanduja SK, Felder TB, Illich PA, Dial EJ, Lichtenberger LM. Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats. Aliment Pharmacol Ther 1997;11:899–906.
  • Lanas A, Arroyo MT, Esteva F, Cornudella R, Hirschowitz BI, Sainz R. Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. Gut 1996;39:654–60.
  • Olbe L, Cederberg C, Lind T, Olausson M. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol 1989;Suppl 166:27–32.
  • Chiverton SG, Howden CW, Burget DW, Hunt RH. Omeprazole (20 mg) daily given in the morning or evening: a comparison of effects on gastric acidity, and plasma gastrin and omeprazole concentration. Aliment Pharmacol Ther 1992;6:103–11.
  • Buerke M, Pittroff W, Meyer J, Darius H. Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. Am Heart J 1995;130:465–72.
  • Pedersen AK, FitzGerald GA. Dose related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med 1984;311:1206–11.
  • Kashfi K, McDougall CJ, Dannenberg AJ. Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clin Pharmacol Ther 1995;58:625–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.